Levi Strauss & (LEVI)
Search documents
Levi Strauss Stock Falls as Profit Forecast Weighs
Schaeffers Investment Research· 2025-10-10 15:23
Core Insights - Levi Strauss & Co's stock has dropped sharply by 10% to $22.07, despite strong third-quarter results, primarily due to a disappointing annual profit forecast [1] - Three analysts have raised their price targets for Levi Strauss, with J.P. Morgan increasing its target from $23 to $33 while maintaining an "overweight" rating [1] Stock Performance - The stock is moving away from its recent three-year high of $24.82 reached on October 3, with a low of $21.11 observed today [2] - Year-to-date, the equity has increased by 27.4% [2] Options Activity - Options trading has surged, with 12,000 calls and 8,963 puts exchanged, exceeding typical daily volume by more than ten times [4] - The most popular options are the October 24 put and the October 23 call [4] - Short interest has decreased by 17.4% over the last two weeks but still represents 9% of the stock's available float, indicating it would take over three days for shorts to cover at the average trading pace [4]
Levi Strauss Stock Tanking After Q3 Is Buying Opportunity, Says Analyst
Benzinga· 2025-10-10 15:19
Core Insights - Levi Strauss & Co reported strong third-quarter earnings, with adjusted earnings of 34 cents per share, surpassing expectations of 31 cents per share, driven by a 7% year-on-year organic revenue growth and a gross margin expansion of 110 basis points [2][3] Financial Performance - Total revenue increased by 7% to $1.543 billion, exceeding the consensus estimate of $1.499 billion, which was projected to grow by 3.9% [5] - The company's organic revenue growth rate accelerated to 10.9% on a two-year stacked basis, indicating robust performance across regions [3] Guidance and Projections - Management raised the 2025 adjusted earnings guidance to a range of $1.27-$1.32 per share, up from the previous estimate of $1.25-$1.30 per share [3] - Full-year organic sales guidance was increased to 6%, up from the prior projection of 4.5%-5.5% [4] Market Sentiment and Analyst Ratings - Despite the positive earnings report, shares of Levi Strauss declined by 11.94% to $21.61, attributed to negative market sentiment [6] - Analysts maintain positive ratings, with JPMorgan raising the price target from $23 to $33, while BofA Securities and Telsey Advisory Group set targets of $27, and Needham at $28 [8]
Levi Strauss falls 10% after cautious Q4 outlook affected by tariff worries
Invezz· 2025-10-10 14:44
Core Insights - Levi Strauss & Co. reported stronger-than-expected third-quarter results and raised its full-year guidance, yet shares fell sharply on Friday, indicating investor skepticism despite positive financial performance [1] Financial Performance - The company achieved better-than-expected results in the third quarter, which contributed to an increase in its full-year guidance [1] Market Reaction - Despite the positive earnings report, investors reacted negatively, leading to a significant drop in the company's share price [1]
Levi Strauss (LEVI) Q3 2025 Earnings Transcript
Yahoo Finance· 2025-10-10 13:53
Our growth was led by continued strong sales and profitability in our direct-to-consumer channel, up 9%, fueled by strong comp growth as well as solid performance in global wholesale. Our largest market, the US, grew 3%, and our international business was up 9%, led by an acceleration in Asia. And we continue to see robust performance in our core as well as outsized growth in our key focus areas like women's and tops. The results we've delivered this quarter against an increasingly complex backdrop are yet ...
China ramps up crackdown on Nvidia chip imports, US government shutdown shows no signs of easing
Youtube· 2025-10-10 13:52
[Music] Hello and welcome to Morning Brief Market Sunrise. I'm Raman Karamali live from Yahoo Finance Studios in London. It's Friday 10th October.Coming up on the show, will any side crack as the government shutdown continues. China ramps up its crackdown on chip imports with Nvidia clearly in focus. And what's the spookiest thing about Halloween.The price of chocolate. So, grab your coffee and let's own the morning. Okay, we kick off with some breaking news.According to China's state media, Beijing is prob ...
Levi's shares slide as tariff concerns overshadow Q3 earnings beat
Proactiveinvestors NA· 2025-10-10 13:12
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
5 Things To Know: October 10, 2025
Youtube· 2025-10-10 11:00
Five things to know ahead of uh the opening bell. China opening a probe into Qualcomm for allegedly violating antitrust laws according to the country's market regulator. The investigation centers on Qualcomm's purchase in June of a vehicle technology company called Auto Talks.Levi Strauss u reporting results that were above estimates. Profits are growing more than expected despite some higher costs from the tariffs uh thanks to some targeted price increases and a shift away from wholesalers. The shares thou ...
Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday - Levi Strauss (NYSE:LEVI)




Benzinga· 2025-10-10 06:53
Company Performance - Apogee Enterprises Inc. reported better-than-expected second-quarter financial results, with shares gaining 1.4% to $42.00 in after-hours trading [2] - Levi Strauss & Co. reported third-quarter earnings of 34 cents per share, exceeding the analyst consensus estimate of 31 cents per share, and quarterly sales of $1.543 billion, surpassing the estimate of $1.501 billion; however, shares fell 7.7% to $22.65 in after-hours trading [2] - VolitionRX Ltd. announced a public offering of common stock and common stock warrants, leading to a 20% dip in shares to $0.48 in after-hours trading [2] - USANA Health Sciences Inc. reported preliminary third-quarter results with an adjusted loss of 15 cents per share and sales of $214.00 million, resulting in an 11.4% decline in shares to $23.26 in after-hours trading [2] - Nurix Therapeutics Inc. reported worse-than-expected third-quarter financial results, causing shares to fall 5.7% to $10.24 in after-hours trading [2]
Levi Strauss Stock: Despite A Strong Showing, It's Time For A Downgrade (NYSE:LEVI)
Seeking Alpha· 2025-10-10 03:02
Crude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, in-depth cash flow analyses of E&P firms, and live chat discussion of the sector.Sign up today for your two-week free trial and get a new lease on oil & gas! ...
Levi Strauss: Despite A Strong Showing, It's Time For A Downgrade
Seeking Alpha· 2025-10-10 03:02
Core Insights - Crude Value Insights provides an investment service and community focused on the oil and natural gas sector, emphasizing cash flow generation and growth potential [1] - Subscribers benefit from a model account featuring over 50 stocks, detailed cash flow analyses of exploration and production (E&P) firms, and live discussions about the industry [1] Subscription Offer - A two-week free trial is available for new subscribers, allowing them to explore the oil and gas investment opportunities [2]